Merdad Parsey
Patrimonio netto: 216 560 $ in data 31/08/2026
Patrimonio netto: 216 560 $ in data 31/08/2026
Il Dr. Merdad V. Parsey è un amministratore indipendente di Arcus Biosciences, Inc. e un Chief Medical Officer di Gilead Sciences, Inc. Fa parte del Consiglio di amministrazione di Arcus Biosciences, Inc. e Sagimet Biosciences, Inc. Il Dr. Parsey è stato precedentemente impiegato come direttore medico senior presso Regeneron Pharmaceuticals, Inc., come direttore senior del gruppo medico presso Genentech, Inc., come direttore medico associato presso Merck & Co., Inc., come direttore di medicina critica presso la New York University School of Medicine, come membro del Roche Group e come direttore medico senior presso Sunovion Pharmaceuticals, Inc. Ha ricevuto il suo dottorato dall'Università del Maryland.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ARDELYX, INC. 0,02% | 16/06/2026 | 57.291 ( 0,02% ) | 216 560 $ | 31/08/2026 |
| 18/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Direttore/Membro del Consiglio | 28/04/2025 |
| ARDELYX, INC. | Direttore/Membro del Consiglio | 28/04/2025 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Direttore/Membro del Consiglio | - |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Investitore di Private Equity | 01/09/2026 |
| Società | Posizione | Fine |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Amministratore Delegato | 01/01/2019 |
| GILEAD SCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2025 |
| ARCUS BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 06/02/2025 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/11/2019 |
| REGENERON PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2004 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 16 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagimet Biosciences, Inc.
Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Gilead Foundation
Gilead Foundation The Gilead Foundation is a company based in Foster City, CA. | |
New York University School of Medicine
New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland Baltimore County
University of Maryland Baltimore County Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale